Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biomarkers in the endometrium

A Berchuck1

  • 1Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC 27710, USA.

Journal of Cellular Biochemistry. Supplement
|January 1, 1995
PubMed
Summary

Key genes like HER-2/neu, c-myc, K-ras, and p53 are altered in endometrial cancer development. These genetic changes, including mutations and overexpression, serve as important biomarkers for cancer progression and patient survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic gene expression signature for high-grade serous ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer.

Gynecologic oncology·2020
Same author

LIFETIME RISK OF OVARIAN CANCER BASED ON ENDOMETRIOSIS AND OTHER RISK FACTORS: IGCS-0014 06. Ovarian Cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2015
Same author

Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC).

Journal of internal medicine·2012
Same author

Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis.

British journal of cancer·2009
Same author

MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition.

British journal of cancer·2009

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Endometrial carcinogenesis involves alterations in oncogenes and tumor suppressor genes.
  • These genetic changes can serve as surrogate biomarkers for tumor transformation and progression.

Purpose of the Study:

  • To review the role of specific oncogenes and tumor suppressor genes in endometrial cancer.
  • To identify potential biomarkers for early detection and therapeutic strategies.

Main Methods:

  • Review of existing literature on genetic alterations in endometrial adenocarcinoma and hyperplasia.
  • Analysis of the frequency and clinical significance of gene mutations and overexpression.

Main Results:

  • HER-2/neu overexpression (10%) correlates with disease spread and poor survival.
  • K-ras mutations (10-20%) are found in cancers and some hyperplasias, suggesting an early role.
  • p53 mutations (20%) occur late in carcinogenesis and are linked to advanced stage and poor survival.
  • Microsatellite instability is present in ~15% of sporadic endometrial cancers.

Conclusions:

  • Specific genetic alterations (HER-2/neu, K-ras, p53) are key events in endometrial carcinogenesis.
  • These biomarkers are associated with disease progression and patient outcomes.
  • The presence of premalignant lesions and biomarkers supports the feasibility of chemoprevention trials.

Related Experiment Videos